These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 4905152
1. L-asparaginase activity in plasma and other biological fluids. Schwartz MK, Lash ED, Oettgen HF, Tomato FA. Cancer; 1970 Feb; 25(2):244-52. PubMed ID: 4905152 [No Abstract] [Full Text] [Related]
3. L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure. Rizzari C, Zucchetti M, Conter V, Diomede L, Bruno A, Gavazzi L, Paganini M, Sparano P, Lo Nigro L, Aricò M, Milani M, D'Incalci M. Ann Oncol; 2000 Feb; 11(2):189-93. PubMed ID: 10761754 [Abstract] [Full Text] [Related]
8. Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized mice. Baechtel S, Prager MD. Cancer Res; 1973 Aug; 33(8):1966-9. PubMed ID: 4578567 [No Abstract] [Full Text] [Related]
10. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia. Nath CE, Dallapozza L, Eslick AE, Misra A, Carr D, Earl JW. Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071 [Abstract] [Full Text] [Related]
11. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators. Holland JF, Ohnuma T. Cancer Treat Rep; 1981 Feb; 65 Suppl 4():123-30. PubMed ID: 7049376 [Abstract] [Full Text] [Related]